Podcast appearances and mentions of kevin wang

culture nba finals overload game 6 leif kevin wang giancarlo navas brian goins

Play Episode Listen Later Sep 28, 2020 71:18

Giancarlo Navas, Brian Goins, BrassJazz, Franky Garcia, Leif, Alex Toledo, Jack Alfonso, Ryan Cortes and Kevin Wang join us. WE CELEBRATE GOING BACK TO THE NBA FINALS CLICK FOR THE DISCORD CHAT INVITE https://discord.gg/Z6mPvGP STREAMS ON Twitch.Tv/MiaHeatBeat

277: Blown Chance // Boat Burning Time? (Game 5 Reaction)

heat boats burning blown spo time game kevin wang giancarlo navas our twitch brian goins

Play Episode Listen Later Sep 26, 2020 47:36

Giancarlo Navas, Brian Goins, Nekias Duncan and Kevin Wang join us. We react to game 5 of the ECF • Nekias breaks down the Heat's blown chance • We look at the adjustments Spo could make • We vent about how the second half • Our Twitch chat lobbies for Gianni to get marries ...and more!!! CLICK FOR THE DISCORD CHAT INVITE https://discord.gg/Z6mPvGP STREAMS ON Twitch.Tv/MiaHeatBeat

Haseeb Qureshi and Kevin Wang: Nervos' Strategy in China

Chain Reaction

Play Episode Listen Later May 6, 2020 64:05

Host Tom Shaughnessy talks to Haseeb Qureshi, Managing Partner at Dragonfly Capital ($100M fund) and and Kevin Wang, co-founder of Nervos. On this episode the three discuss the benefits of a localization strategy in China, competition between layer-1 blockchains, what makes Nervos different (specifically token economics and sustainability are covered) and much more. If you enjoy this episode, please share it! Video Can Be Viewed Here: https://youtu.be/fubeSokngY8 Access Delphi's Research Here: https://www.delphidigital.io/ Resources Mentioned: Haseeb's Twitter: https://twitter.com/hosseeb Kevin's Twitter: https://twitter.com/knwang Nervos: https://twitter.com/NervosNetwork Chain Reaction YouTube: https://www.youtube.com/channel/UC9Yy99ZlQIX9-PdG_xHj43Q Chain Reaction Twitter: https://twitter.com/chainpodcast Tom Shaughnessy Twitter: https://twitter.com/Shaughnessy119 Support The Show Check Out Delphi Digital's Research https://www.delphidigital.io/ ZenLedger is the official tax software of Chain Reaction for crypto investors and accountants. Get a 15% discount when you use code Chain15. https://bit.ly/3bundEl Visit Delta Exchange For A $10 Welcome Bonus! https://www.delta.exchange/Tom Disclosures: This podcast is strictly informational and educational and is not investment advice or a solicitation to buy or sell any tokens or securities or to make any financial decisions. Do not trade or invest in any project, tokens, or securities based upon this podcast episode. The host may personally own tokens that are mentioned on the podcast. Tom Shaughnessy owns tokens in ETH, BTC, CKB, STX, SNX, RUNE, sUSD, and HNT. Lets Talk Bitcoin is a distribution partner for the Chain Reaction Podcast, and our current show features paid sponsorships which may be featured at the start, middle, and/or the end of the episode. These sponsorships are for informational purposes only and are not a solicitation to use any product or service.

china strategy managing partners btc eth rune chain reaction stx haseeb qureshi hnt snx kevin wang zenledger tom shaughnessy

Business Advice Amid COVID-19: Process Improvement and Internal Controls

The Wrap

Play Episode Listen Later Apr 15, 2020 24:50

In the COVID-19 pandemic, companies have been forced to make changes to their operations that otherwise may not have been made, and for many, that provides an opportunity to evaluate the efficiency and effectiveness of their processes. As companies adapt to the changing world, how can you help your team adapt their own tasks in a way that's beneficial for the business?In this special edition episode of The Wrap, our hosts welcome two internal controls and data analytics experts, Sarah Beth Magette, CPA and Kevin Wang, CPA, CGFM, to discuss how companies can turn today's challenges into opportunities for process improvement. Discussion in this episode of The Wrap includes:· Tips for creating an efficient and effective remote working environment for your employees· Considerations for automating tasks within your business· Processes concerning cash that should be conducted differently in a remote environment· Why fraud cases are expected to increase in the coming weeks· Specific ways businesses can leverage their data in order to make strategic improvements This episode reflects our views at the time this podcast episode was released and should be used as reference only. We recommend that you talk to your Warren Averett advisor, or another business advisor, for the most current information or for guidance specific to your organization.

covid-19 tips wrap amid cpa considerations processes business advice amid covid process improvement internal controls kevin wang

Pandemic Hospital Cleaning with Kevin Wang of PowerPlus DCU

Disaster Podcast

Play Episode Listen Later Apr 9, 2020 35:42

Pandemic hospital clean-up is the topic of conversation this week on the Disaster Podcast. Join hosts Jamie Davis, the Podmedic, and Sam Bradley, along with Becky DePodwin as they chat with Kevin Wang from PowerPlusDCU.com. Kevin’s company is one of the premier disaster clean up specialists in the world. A few years [...] The post Pandemic Hospital Cleaning with Kevin Wang of PowerPlus DCU appeared first on Disaster Podcast.

pandemic hospitals cleaning jamie davis kevin wang sam bradley

A Blood Test to Detect Traumatic Brain Injury

Radio Cade

Play Episode Listen Later Apr 1, 2020

Traumatic brain injury (TBI) is hard to detect, and is sometimes called the “invisible injury.” Ron Hayes and Nancy Denslow, both scientists at the McKnight Brain Institute and the founders of Banyan Biomarkers, have developed a blood-based test that will make TBI detection and treatment easier and faster. One potential application is to detect brain injury in newborn infants. *This episode was originally released on April 1, 2020.* TRANSCRIPT: Intro: 0:01 Inventors and their inventions. Welcome to Radio Cade, the podcast from the Cade Museum for Creativity and Invention in Gainesville, Florida. The museum is named after James Robert Cade who invented Gatorade in 1965. My name is Richard Miles. We’ll introduce you to inventors and the things that motivate them. We’ll learn about their personal stories, how their inventions work, and how their ideas get from the laboratory to the marketplace. Richard Miles: 0:41 This morning, we have Dr. Ron Hayes , one of the co-founders of Banyan Biomarkers with us. Welcome, Ron . Ron Hayes: 0:46 Thank you. Richard Miles: 0:47 So Ron , before we start talking about Banyan Biomarkers and what a biomarker is and what it does, tell us a little bit about yourself. Where were you from? Where’d you grow up and how did you decide to become a scientist? Ron Hayes: 0:58 I grew up in Richmond, Virginia in the fifties at the time, it was a, quite a conservative time , uh , somewhat isolated, really a classic vision of the old Seth. My undergraduate major at the University of Richmond was classical languages. And , uh, then I did some graduate work in philosophy. So it’s surprising sometimes to find myself , uh , here today. But if we want to elaborate at some point, I think it’s been a benefit for me to have a liberal education. Richard Miles: 1:30 Tell us a little bit about what you’re like as a kid where you were very curious, sort of interested in everything. And when did you sort of know you wanted to gravitate towards a scientific field Ron Hayes: 1:39 As a kid, I didn’t know. I read voraciously wasn’t , uh , much of a sports person. I, although I ultimately ended up playing competitive tennis later in life, but at that time I was really quite focused on reading Richard Miles: 1:57 Really? Okay. Did you have a teacher that stood out or were either of your parents? So what did they do, were they scientist engineers, doctors? Ron Hayes: 2:07 No, I was the first person in my family to go to college. They, they encouraged reading. Uh, they , uh, certainly liked to see me do it, but , uh, as I reflect, it was sort of a self-taught environment. And I read anything put in front of me. Richard Miles: 2:25 Tell us a little bit now , uh, let’s talk about biomarkers , uh, for folks who don’t know what that means, what is a biomarker? How does it work? Ron Hayes: 2:34 It’s an indicator of , uh, the organic state of an individual or an animal that provides in a medical situation information on the health or the disease state of the person. And a biomarker can be a variety of different things. It could be information from the blood such as we use in, in, in our, or it could be an image of the body. It could be a recording of bodily activity, such as heart rate, but any of these things collectively are referred to as biomarkers and they’re used to assist in the diagnosis of health and disease. Richard Miles: 3:16 So in, in the case of Banyan Biomarkers, you’ve come up with the specific use here, dealing with traumatic brain injury, explain how the biomarker net instance works or indicates what you want it to indicate. Ron Hayes: 3:30 I think the best analogy would probably be a heart attack. Okay. So all of us today, I think can understand if we have very severe chest pain and persistent chest pain, we’ll go to an emergency room. And the first thing they’ll do is draw blood and they’ll look at the level of a protein in the blood called traponin, but it happens to be a protein that’s in muscle cells of hearts. And if the muscle cells are injured or dying, of course, that protein escapes into the blood and if there’s a lot of it, you know, you’re having a heart attack. In many ways it’s a similar process for the brain. If the brain is injured and brain cells, neurons are supportive, cells called golia are injured or dying they shed proteins that can show up in the blood. For a long time people didn’t believe that was possible. There was a blood-brain barrier that whatever went on in the brain stayed in the brain, but every search helped discount that prejudice. So we measured those proteins in the brain. If they’re elevated, you have some form of brain injury in this case, traumatic brain injury. Richard Miles: 4:39 So is the real breakthrough here. The fact that we can do that now through blood, as opposed to, I guess, an MRI would be the next best way of diagnosing a traumatic brain injury. Is that correct? Ron Hayes: 4:50 In essence, yes. I mean , it was , uh , a violation of orthodoxy that in some ways had prevented people from just doing it. And it’s far cheaper, a blood test obviously is far cheaper than what’s called a computerized tomographic scan or a CT scan or an even more expensive MRI. In fact, magnetic resonance imaging isn’t used in clinical practice. It’s primarily , uh , in acute clinical care, it’s primarily a diagnostic tool reserved for neurodegeneration or elective processes. But if you show up at an ER, you’ll get a CT scan, not an MRI. Richard Miles: 5:29 So I’m guessing there’s a , there’s a whole range of applications out there in which you might have some sort of brain injury, but it would simply be too complicated, costly, complex to actually do a CT or MRI. Is that really a now the main advantage of , of being able to do it by blood? Ron Hayes: 5:46 That’s one important advantage is that you can triage or you can stage people and tell them whether or not they need to CT. And you really would like to avoid that if possible for a number of reasons, Richard Miles: 6:00 Avoid the CT. Ron Hayes: 6:00 Avoid the CT scan. Absolutely because they’re of course expensive. They increased the time in the emergency rooms, which is always critical, but even more importantly, there’s a lot of radiation exposure to CT scans. And you certainly don’t want to do that unnecessarily. Richard Miles: 6:20 Tell me a little bit about the formation of the company. So you, you and Nancy, and were others involved in the original invention? Ron Hayes: 6:28 Uh , one other founder, Kevin Wang. Richard Miles: 6:31 So after you hit upon the idea, or you figured out that you could do this, did you just get together and say, Hey, let’s form a company and see if we can market this, or tell us a little bit about how that happened. Ron Hayes: 6:41 Uh , those kinds of events are sort of like , uh , a marriage. You know, you never quite know what the precipitating moment was , uh, in a long chain that leads to , uh , that union. But I would say it was a perfect storm of time and place and people. And I had been asked by NIH to look at a technology related to biomarkers and got interested in it, talked to Nancy Denslow because she knew a lot more about protein chemistry than I did, and was also collaborating with Kevin Wang who had some interesting ideas about brain injury processes. So in that stew , the company was gridlocked. Yeah. Richard Miles: 7:26 What year was that again Ron? Ron Hayes: 7:27 We formed Banyan in 2002, Richard Miles: 7:30 2002. Okay. And how’s it doing now? Do you have big clients or who is buying the process? Ron Hayes: 7:37 That’s a very interesting story. And I think for young entrepreneurs, I would advise them to be nurtured by their naivety, because if they knew what they were doing from conception, they might’ve been less bold, but Banyan it take, which I didn’t understand at the time, between about $150 to $200 million dollars to bring a biomarker through the FDA. And we were fortunate, Richard Miles: 8:02 So let me stop you, $150 $200 million dollars? Ron Hayes: 8:05 Yes. Well, and that’s chump change compared to a therapy, which is multiple billions of dollars. Richard Miles: 8:13 So for our listeners who aren’t familiar with FDA approval process for drugs and pharmaceuticals and treatments, why does it take that long, and that much money? Ron Hayes: 8:22 That’s a subject of obvious controversy. And when I entered into the process, I entered into it with the same kind of concerns and skepticism that people often bring to the FDA process. That said having lived through it, a lot of the time is justified. And the process of diagnostics, if you want to generate data that influences potentially a life or death medical decision, you have to be absolutely certain of the technologies’ performance and reliability in the case of medical devices that take some time. Richard Miles: 9:00 I see. So it’s not like a, a drug that you have to make sure is , uh , safe and won’t hurt somebody. But the fact that these tests will be used to make those types of decisions. That’s why the FDA steps in and says, we really need to make sure this works. Ron Hayes: 9:14 In fact, the FDA , uh, has become, I think at least in my own experience, very responsive. The FDA offered and executed, an expedited review. So we got to review and feedback in six months on the basis of what they called their breakthrough technology. So that’s really not a very long period of time. Richard Miles: 9:35 Ron, you’re experienced in this company , uh , you know, a start startup and it sounds like it’s doing well, but as anyone who’s done, a startup knows there are good days and there are bad days. Tell us about one of your best or best day. And tell us if you’d like to one of your worst or the worst day you’ve had in this experience. Ron Hayes: 9:54 There’s a term, an image I often invoke. I was a fighter pilot, and we often describe our missions as long periods of boredom, punctuated by terror or ecstasy as the moment may be. So terror. We were meeting a short there , the company was formed and we had secured some money. And we had a consulting CEO who advised us blandly that we were out of money and with no warning and no mea culpa. Richard Miles: 10:27 So in the jet fighter, now your , your engine just shut down. Ron Hayes: 10:31 Well, I was waiting to light the burners and blow some stuff up, but it was very, very disconcerting, very discouraging and we survived it. Richard Miles: 10:40 How did you turn that around? You went, you had no money and what happened how’d you keep going? Ron Hayes: 10:46 Well, we were very fortunate to get congressional support from the Florida delegations, actually, Congressman Bill Young, who’s passed away in Tampa as well as Congressman Sterns who’s no longer here. And we got some congressional support through the DOD, which ultimately morphed into sustained support because a department of defense really pioneered interest in this technology because of the Wars, unfortunately in Afghanistan. Richard Miles: 11:14 I see because this is a , a much easier way to assess traumatic brain injury on the battlefield, I’d take it. Ron Hayes: 11:20 Yes. And of course, having a CT scanner in a far forward medical, environment’s extremely difficult. And you could say, get this person back for a CT scan or not. Got it. Richard Miles: 11:31 So, Ron, tell us about some of the future applications of the Banyan biomarkers. Ron Hayes: 11:37 Well, there are many applications I’ll focus on one that is particularly close to my heart, and that is assessing in a diagnosis and the treatment of brain injury that occurs during birth. Richard Miles: 11:51 Birth? Ron Hayes: 11:52 During birth. This is the kind of injury that can result in cerebral palsy, where at birth, the blood flow to the baby and the brain is interrupted at a very critical period. So the brain is quite vulnerable. This can lead to minimally delayed development, and of course, death to that extreme my own son, aspirated meconium at birth, and he had an event. And of course, any parent can understand confronting that at birth. So by rapid diagnosis from even your umbilical cord blood, you can intervene quickly and appropriately. There is in fact, a treatment where you cool the baby’s hypothermia, so you can quickly determine the baby’s need, and whether they’re a good candidate for the treatment and working closely with a very dedicated neonatologist at the University of Florida, Dr. Mike Weiss has done a marvelous job of leading this effort. Richard Miles: 12:49 So absent of using the biomarkers, Ron , if I understand correctly, would the brain injury go undetected until later? Because are there no necessarily obvious signs of that event? Ron Hayes: 13:01 There are signs, but it’s not as rigorous and as definitive as a blood test. So the blood test would provide a very rapid and definitive test. It’s just like a concussion Richard Miles: 13:15 Right. Ron Hayes: 13:15 A brain injury, the what’s called a Glasgow coma scale is quite subjective. You want a hard number quickly. Richard Miles: 13:21 Right. And so, and in a blood test, of course, the standard at right after the baby’s born. So it would be something that would be picked up in all babies potentially right? Ron Hayes: 13:29 Ultimately , uh , I would look at it as every parent wants to know, is my baby. Okay? And short of what’s called the app guard test a very crude test. You don’t know that. And of course you wouldn’t know if the brain’s okay. So this could be available to everyone once it’s , uh, of course, FDA approved, it could be available. Richard Miles: 13:48 That that is exciting. Um , Ron, if , if somebody , uh , uh , a young scientist or entrepreneur came to you and said, I’ve got this brilliant idea, and I’m going to form a company and I hit the big time, what would your advice be to that person? Ron Hayes: 14:02 Don’t do it for money. I think that’s a huge mistake that people make, of course, very broadly in life, but most conspicuously in startups, people labor, I think under the illusions of IT, I’m going to make a what’s up dude app and make a billion dollars and rockstar. In fact, I think it takes a good deal, more maturity, and a willingness to give up ego and a commitment to whatever you’re doing. That’s deeply rooted in your own sense of purpose. Richard Miles: 14:39 Excellent words of advice. Uh , Ron, thank you very much for joining us this morning on Radio Cade. Ron Hayes: 14:44 Thank you. Outro: 14:48 Radio Cade would like to thank the people for their help and support Liz Gist of the Cade Museum for coordinating inventor interviews, Bob McPeak of Heartwood soundstage in downtown Gainesville, Florida for recording, editing and production of the podcast and music theme, Tracy Collins for the composition and performance of the Radio Cade theme song, featuring violinist, Jacob Lawson and special, thanks to the Cade Museum for Creativity and Invention located in Gainesville, Florida.

Kevin Wang: Nervos – Scaling Smart Contact Blockchains With Proof of Work and Generalized UTXO

Epicenter - Learn about Blockchain, Ethereum, Bitcoin and Distributed Technologies

Play Episode Listen Later Feb 11, 2020 84:33

While recent blockchain launches seem to leverage various Proof of Stake consensus mechanisms, some believe Satoshi’s consensus mechanism is optimal for distributed protocols. As decentralized ledgers jockey to become the chain of choice for enterprises looking to leverage blockchain technology, projects are looking to offer a solution that maximizes security, decentralization, and transaction throughput. Kevin Wang, a Co-founder of Nervos, joins us to discuss why Proof of Work was implemented as the consensus mechanism for the network. To enable greater flexibility for application developers, Nervos created a Common Knowledge Base (CKB) to focus on the security of assets, enabling a complementary layer of Virtual Machines (VM) to scale and facilitate computation.Kevin also discusses the active initiatives underway with the Nervos Grants Program to foster ecosystem development and encourage developers to evolve the permissionless network.Topics covered in this episode:Kevin’s background at IBM, his open source development, and journey to cryptoWhat the blockchain scene is like in Hangzhou, ChinaWhat’s unique about Nervos, and the importance of each layer within the networkIntroducing Nervos’ consensus mechanism, NC-MaxWhy Nervos decided to implement Proof of WorkExplaining the Common Knowledge Base (CKB), and its significance in the Nervos networkHow developer experience is in the Nervos ecosystemThe economic model of CKB, Nervos’ native tokenProgress of the network, and a call for developers to consider the recently announced Nervos Grants ProgramEpisode links: The Nervos Network homepageNervos Network on TwitterWhy We Love Nakamoto Consensus - Nervos BlogNervos CKB in a Nutshell - Nervos BlogNervos developer resourcesNervos Telegram channelNervos grant informationSponsors: Pepo: Meet the people shaping the crypto movement - https://pepo.com/epicenterThis episode is hosted by Sebastien Couture & Sunny Aggarwal. Show notes and listening options: epicenter.tv/326

china work smart finance startups bitcoin economics proof blockchain ibm scaling fintech open source stake pow satoshi hangzhou generalized proof of work utxo kevin wang

Episode #5 - Kevin Wang, le citoyen du monde

The Banana Split Project

Play Episode Listen Later Dec 11, 2019 23:00

Kevin vit et travaille depuis 5 ans à Singapour. Il est français d'origine chinoise, ses parents sont arrivés jeunes du Wenzhou ; il est né en France et a grandi à Paris. Il nous raconte son rapport avec sa famille, les valeurs transmises, mais aussi la difficulté à communiquer due à la barrière langagière. Nous découvrirons aussi les rencontres faites à Singapour, et sa grande curiosité pour d'autres cultures. Kevin est à l'aise avec son identité, cela se sent, il aborde la multi-culturalité avec philosophie. Ecoutez pour connaitre son parcours, sa relation avec la Chine, le mandarin, le dialecte du Wenzhou, et la manière dont il se voit évoluer en Asie. C'est passionnant et rafraichissant ! Et après l'épisode, retrouvez-nous sur Instagram et Facebook pour des bonus videos de nos invités et suivre notre actualité !

france du monde chine asie ecoutez singapour citoyen wenzhou kevin wang

FOSSA: Open Source Management with Kevin Wang

Open Source – Software Engineering Daily

Play Episode Listen Later Nov 6, 2019 61:38

Every company has a software supply chain. A company builds its products from custom code, paid APIs, paid proprietary binaries, and open source software libraries. As the types of software available have increased, the management of the software supply chain has become complex. Large software companies have always needed to ensure the security of their The post FOSSA: Open Source Management with Kevin Wang appeared first on Software Engineering Daily.

management large open source apis fossa software engineering daily kevin wang

Nov. 6th: Hong Kong Licensing Requirement For Virtual Asset Exchanges

This Week in Crypto - Bitcoin, Ethereum, Blockchain, and Cryptocurrency News

Play Episode Listen Later Nov 6, 2019 6:02

This is your daily roundup for Wednesday, November 6, 2019. Hong Kong’s SFC releases a position paper on virtual asset exchanges, Cash App restructures its bitcoin fees, and Nervos Network will launch its “Lina” blockchain next week. ☕ Buy Me A Coffee: https://glow.fm/mota Hong Kong Crypto Exchange Position Hong Kong’s Securities and Futures Commission (SFC) has released a position paper on virtual asset exchanges. The paper outlines custody, KYC, and a new licensing requirement for any virtual asset firm trading at least one security token. Decentralized and non-custodial trading platforms will not be reviewed by the SFC. Under the new licensing conditions, regulated crypto exchanges can only offer products to professional investors. Exchanges must also obtain the SFC’s prior written approval for any plan or proposal to add any product to its trading platform and must provide monthly reports to the SFC. Only 2% of assets can be stored on hot wallets. Per the license requirement, exchanges must use a Hong Kong incorporated custodian that is a wholly owned subsidiary of the exchange. An insurance policy must also cover the risks of assets held in both hot storage (full coverage) and cold storage (a substantial coverage) at all times. Lastly, the report says exchanges should take all reasonable steps to establish the true and full identity of each of its clients, and of each client’s financial situation, investment experience, and investment objectives. The regulator also issued a warning Wednesday to providers of cryptocurrency-based futures products targeting Hong Kong citizens without the proper paperwork. The SFC said it has not licensed or authorised any person in Hong Kong to offer or trade virtual asset futures contracts to date and remains unlikely to grant a license. Cash App Bitcoin Fees Square’s Cash App has started charging standalone fees for bitcoin purchases as high as 1.76 percent. The Cash App website now states “Cash App may charge a fee when you buy or sell bitcoin. If so, the fee will be listed on the trade confirmation before you complete a transaction.” A Square spokesperson confirmed that Cash App is rolling out a new fee structure for bitcoin trades. Previously, fees were included in the spread. Now Square says it has broken fees out of the spread for user transparency. The 1.76 percent fee is still favorably for smaller bitcoin transactions when compared to Coinbase. Square reported bitcoin sales of $148 million for its Q3 2019. Security Token Research Consortium Mitsubishi UFJ Financial Group – Japan’s largest financial group and the fifth largest bank in the world by assets – is leading a 22-member Security Token Research Consortium to develop standards around security token management. Securitize is the only issuance platform provider that has joined the consortium. The group is pursuing ways to develop, offer and onboard financial transactions services using blockchain, with a focus on automatic settlement for securities and funds. It plans to develop a dedicated security token blockchain called “Progmat” to provide a platform for managing securitized assets, including trust functions to minimize counterparty risk. Mitsubishi UFJ Financial Group is also developing a blockchain payments network with fintech company Alkami Technologies to be launched in the first half of 2020. The company is also participating in a blockchain proof-of-concept to streamline KYC processes with HSBC Singapore, OCBC Bank and the Info-communications Media Development Authority. Nervos Network Launch Nervos Network plans to launch its “Lina” blockchain next week on Nov. 16. It’s estimated that the startup raised $72 million in its three-week token sale. Investors included China Merchants Bank International (CMBI), Polychain Capital, Blockchain Capital, Hashkey, MultiCoin and Distributed Global. According to co-founder Kevin Wang, the mainnet will enable users to build applications on their blockchain without facing the tradeoff between scalability and security. The company’s new CKByte token entitles holders to storage space on the blockchain, acting as an incentive mechanism for miners and acting as a resource management tool. The company has established its significant presence in the Chinese developers’ community as some of the core team members are among the earliest ethereum developers in China. EU Stablecoin Regulation According to Reuters, a group within the EU presidency is working on a draft political declaration that will say the EU should regulate stablecoins in particular. The declaration is being developed in response to Libra, with a focus on how stablecoins should be regulated. A source told CoinDesk “The statement is to highlight the need for a proper regulatory framework for those stablecoins and as a consequence, different ideas should be explored. One of them is the possibility of having something that is managed by the ECB [European Central Bank] and other central banks.” The declaration is expected to be adopted by the EU on Dec. 5, at the finance ministers’ next meeting

Behold my servant: crushed and glorified

Austin Chinese Church

Play Episode Listen Later Oct 13, 2019 32:35

As Jesus revealed that all of the Old Testament is pointing to him (Luke 24:27), in the 4th Servant Song of Isaiah we have clear picture of God’s plan of redemption for His people. We will explore the dramatic nature of this song and thus have a more profound understanding of Christ’s cross and glorification. - Kevin Wang

god jesus christ old testament crushed glorified behold my servant servant song kevin wang

Kevin Wang, VP of Product at Braze

Frontier Podcast by Gun.io

Play Episode Listen Later Oct 7, 2019 23:19

Ledge sits down with Kevin Wang, VP of Product at Braze, to share how they are leading the way in helping brands such as Microsoft, Citi, Postmates,and KFC to build rich relationships with their customers. See acast.com/privacy for privacy and opt-out information.

microsoft product kfc citi postmates ledge braze kevin wang

138: Kevin Wang co-founder of Nervos

The Blockchain Show

Play Episode Listen Later Sep 16, 2019 41:50

Kevin Wang is a co-founder of Nervos, a public blockchain designed by a former Ethereum core developer and backed by Sequoia, Polychain, and others. As one of China's top projects, Nervos recently partnered with crypto exchange Huobi to build a new public chain for banks and financial institutions. Kevin was responsible for Nervos' unique token economics design where users will eventually pay "rent" to store assets and smart contracts on the network. He believes this type of model is critical if blockchains are to scale. Same goes for the layered design, which splits the public consensus layer from the transactional layer to increase a blockchain's performance while balancing security and trust. This episode is brought to you by AXEL.Network connect with them on Discord, Twitter and Medium

china co founders network ethereum sequoia huobi polychain kevin wang

Ep. 262 - Peeling Back Layer 2: Scaling Solutions w/ Nervos Network

CRYPTO 101

Play Episode Listen Later Sep 5, 2019 28:59

Today we are peeling back blockchain's "layer 2" with Kevin Wang of Nervos Network. It is the way our beloved crypto networks will try to tackle the throughput problem, until blockchain can reach the same speeds as the Visa Network some day. Researcher and co-founder of Nervos, Kevin Wang takes us on a ride into the future. We learn about State channels and side chains. We also take a look at security, decentralization and performance tradeoffs when creating and scaling a blockchain. We also take a look at tradeoffs between block size, block times, etc. We cover lots of info about miners and securing the network, and the game theory behind mining. This episode got a lot more technical than most of our episodes, but it will be something fresh for everyone to listen to and learn about. Guest Links: https://twitter.com/NervosNetwork https://twitter.com/knwang Show Links: CRYPTO101podcast.com Episode brought to you by BRD. https://brd.com Patreon: www.patreon.com/user?u=8429526 Twitter: twitter.com/Crypto101Pod twitter.com/BrycePaul101 twitter.com/PizzaMind www.instagram.com/crypto_101 Facebook: https://www.facebook.com/groups/101Crypto/ https://www.facebook.com/CRYPTO101Podcast/ **THIS IS NOT FINANCIAL OR LEGAL ADVICE** © Copyright 2019 Boardwalk Flock, LLC All Rights Reserved ▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬ Fog by DIZARO https://soundcloud.com/dizarofr Creative Commons — Attribution-NoDerivs 3.0 Unported — CC BY-ND 3.0 Free Download / Stream: http://bit.ly/Fog-DIZARO Music promoted by Audio Library https://youtu.be/lAfbjt_rmE8 ▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬Advertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy

state network researchers scaling audio library free download stream brd peeling back layer 2 unported cc by nd kevin wang dizaro

Ep. 262 - Peeling Back Layer 2: Scaling Solutions w/ Nervos Network

CRYPTO 101: with Matthew Aaron

Play Episode Listen Later Sep 5, 2019 28:59

state network researchers scaling layer audio library free download stream brd peeling back unported cc by nd kevin wang dizaro lafbjt rme8

#66 Nervos: Can Smart Contract Platforms be Stores of Value? | Asia Series w/ Kevin Wang

Blockcrunch: Crypto Deep Dives

Play Episode Listen Later Aug 28, 2019 67:04

Nervos, a highly discussed project in China, takes a novel approach to building a smart contract platform that accrues value to the native asset. Kevin Wang joins me as part of the Asia series to discuss: Why Nervos will be the only PoW smart contract platform Why stake centralization is worse than mining centralization How Nervos solves the state bloat problem and accrues value Host: Jason Choi (@MrJasonChoi). If you enjoyed the show, consider tipping! This show is not financial advice. BTC: 3EFSLnPpme6Lo6DynN1bVV9owooueFvEmJ ETH: 0xdec40AA30B9C562aB4b839529BfC290C1B5Da61E ****** Resources: Relay node newsletter (Asia crypto events) Libsyn link Apple Podcast Stitcher Spotify ****** Disclaimer: Jason Choi is an investor at Spartan Capital, the hedge fund arm of The Spartan Group. All opinions expressed by Jason and podcast guests are solely their own opinions and do not reflect the opinion of The Spartan Group and any of its subsidiaries and personnel. This podcast is for information purposes only and should not be relied upon as a basis for investment decisions. The Spartan Group and its clients may hold positions in assets described in the episode. Detailed disclaimers available at jasonchoi.me and spartangroup.io/disclaimer Copyright free music credit: Track Name: "Better Days" Music By: LAKEY INSPIRED @ https://soundcloud.com/lakeyinspired Original upload HERE - https://www.youtube.com/watch?v=RXLzv... Official "LAKEY INSPIRED" YouTube Channel HERE - https://www.youtube.com/channel/UCOmy... License for commercial use: Creative Commons Attribution 3.0 Unported "Share Alike" (CC BY-SA 3.0) License. Full License HERE - https://creativecommons.org/licenses/... Music promoted by NCM https://goo.gl/fh3rEJ

001: New Kids on the Blockchain

The Wrap

Play Episode Listen Later Aug 9, 2019 20:04

Blockchain is an increasingly hot-button topic, and business owners are attempting to predict how this revolutionary technology will impact their companies. We know that blockchain is expected to transform the ways that businesses conduct their financial operations and accounting systems, but what should business leaders know now in order to set their companies up for future blockchain success? In this episode of The Wrap, Kevin Wang and Dana Canterbury join Kim and Paul to define blockchain, discuss its current state and forecast what blockchain's implications may be in the future.

wrap bitcoin blockchain new kids kevin wang

Episode 16: Emerging Channels

Braze for Impact

Play Episode Listen Later May 28, 2019 27:01

Our very own Kevin Wang, VP of Product, sat down with me in our San Francisco office to discuss some of the recent SaaS IPOs (Zoom, Slack, PagerDuty) as well as the latest emerging channels and what the future may hold. TRANSCRIPT: [0:00:17] PJ Bruno: Hey again. Welcome back to Braze for impact your MarTech Industry Discuss Digest. I have with me a very good friend today. Kevin Wang or Kevin Wang. Both are correct? [0:00:28] Kevin Wang: Both are correct enough. I like it pronounced right, but I also like it spelled right and so we can go with either. [0:00:35] PJ Bruno: That's W-A-N-G for all you listening. This is Kevin Wang on Kevin Wang, VP of product at Braze. I'm so glad we finally got to do this man. This has been a long time coming. [0:00:43] Kevin Wang: I know, I know it. Really excited to be here. [0:00:45] PJ Bruno: Well, we're kind of coming off MAU. Both of us are a little bit tired, but we needed to get ourselves together for this. The communications episode, some sass IPOs that went on in April, all around communication. So our first up is Zoom. Now I know, Kevin, this one was a really interesting IPO for you, right? [0:01:04] Kevin Wang: Yeah. Zoom, I think it's fascinating. So in addition to just being an incredible business, I think one of the things that's really neat about zoom is the fact that they've been so successful. Essentially just literally building the proverbial better mouse trap. It's the thing where they already had a really powerful captive audience that's actually growing, in a large way as remote work continues to get more popular, where we've got all these folks who need to do video conferencing and the existing tools, I mean, we've all used them like a lot of the tools out there, just not that good. And Zoom literally just they knew all about the system. A lot of them are ex Cisco folks and they looked at the situation, just said, "We know how to do this better." And so, I think that, as a product person and as someone who thinks a lot about how we build products and how one makes products, I think there's a very strong pull in the industry to try to be completely out of the box, off the wall innovative. And I almost say, "Air quotes, innovative." With the idea of people wanting to build things that were never seen before. So let's look at a company like SpaceX, like reusable rockets. There's not a cottage industry of reusable rocket launch and orbital delivery products out there. And zoom looks at it from a completely different way. It would be like if they were looking at Honda civics or something like that, and they were like, "We can just build a Honda civic that's like the same price, just 20% better." In what way is it better? "It's just better." And I have a huge amount of respect for that because there's already that huge market there, and they knew exactly what they want. You just do it better. And delivering on that I think is really impressive. [0:02:39] PJ Bruno: Right. I mean, do you think that also makes them equally vulnerable for someone to come along and create a Honda civic that's 40% better or? [0:02:48] Kevin Wang: I think it isn't. So I've read a bit about zoom, especially in the wake of how successful their IPO has been because you look at the numbers, it's pretty eye-popping and at least in their case, they actually had a lot of knowledge of the space at a very, very high technical level, but also had the ability to execute really rapidly product wise. And I think that that was a huge advantage for zoom. And that's not something that's particularly easy to replicate. There are perhaps other teams out there that could do that, but it's not like there's tens of thousands of teams who could just try, and make a better version. So it's a very interesting, almost pure technology, defensible mode. Because one thing that's pretty common, I think, in the tech industry is that companies end up very able to defend their place in the market because they have a huge network effect and that gives them more data that gives them more customers. So Facebook, Google, they're both examples of doing this. In zooms case, that's not necessarily the game that they're playing. It's literally just knowing the problem and the technology better and then executing really, really well. A very interesting contrast to that would be PagerDuty, which is another one of these recent tech Ipos. [0:04:00] PJ Bruno: PagerDuty, when I took a look at this outline, this is the only one that I didn't know. So PagerDuty, it has to do with pagers? It's bringing back pagers were going to go retro and we're... [0:04:10] Kevin Wang: Yeah, they go out there and they just sell pagers just door to door and it's, they're really cool. There are at ease and all like wood and a little bit of gold plating. [0:04:17] PJ Bruno: Bringing back the door to door salesman too. [0:04:20] Kevin Wang: Yeah. It's everything. PagerDuty's business is that they essentially help an operations team for technical operations, running servers and things like that run better and they will page you in the old school sense. They will actually page folks saying, "Hey, this server, this system is down. You need to go in there and fix it." Because when we're talking about these really large distributed technical systems, you have hundreds or thousands of servers, they're running all sorts of code and the universe is just a big scary place. It's a big scary place to be running a lot of code and stuff breaks, things happen. And when it happens, you need to very often get somebody to go in and verify what's wrong or fix the problem. And PagerDuty just automates that. But the genius of Pager duty I think is that, often when these systems break, when these very complex systems, a server goes down, it can break in such a bad or catastrophic way that it can't even scream for help. And so there's a huge amount of value in PagerDuty, just literally not being you, the customer just running on their own system because that gives you that additional level of reliability. And additionally, they've done a number of clever things around how you actually run the responses to these incidents that can happen. And so PagerDuty in contrast to zoom is, is really playing more of the game of saying, "Here's how you run your operations better around your servers and your technology." Whereas zoom is just saying, "Hey, you want a video conference, wouldn't it be nice in the video conferencing was better?" And that in itself adds a lot of value and of course assumes that it has added a number of other features on top of it. But their core really did come from almost a very, very pure quality standpoint. [0:06:01] PJ Bruno: Got you. So PagerDuty, effectively it's a third party flag razor. Right? And then it helps a little bit with the next step after the flag is raised. Like who needs to know what step is. [0:06:16] Kevin Wang: Exactly. And they've got some other features there. I'm not doing either of these products, quite the justice that they deserve in terms of the different things that they've added on. But a large part of it is really that communication and inter mediating the communication between whatever is going on with your servers and your team who are actual human beings who need to actually make a decision or take some form of action. [0:06:41] PJ Bruno: Something that I found a little strange as I was doing a little research on Zoom. They're whole thing that the CEO talks about his happiness. He just keeps using it in their pitch happiness, happiness. He says delivering happiness is what we do at zoom. And that just tells me nothing about the product. I love amplitudes, we help companies build better products. Just like these taglines that are like really removed from what actually is going on. I love happiness, don't get me wrong. [0:07:10] Kevin Wang: Yeah, it's a great thing. [0:07:11] PJ Bruno: It's a good thing. But I'd love a little more information. A nice tagline that's really buttoned up and putting it a little boat for me. [0:07:19] Kevin Wang: Yeah, I agree with that. And I think if anything just says something about the state of brand marketing today that really, really enormous visions play quite well in a lot of ways. I mean, just look at car ads. I mean, if you look at a vehicle ad for like a Lexus versus how somebody actually buys a car, it's so completely detached, because people buy cars off of spreadsheets, they buy them basically off of spreadsheets. But the car ad is like, this is the lifestyle represented by whatever vehicle it is that their marketing, it's also like the same lifestyle for all of them or the same two lifestyles. Sunsets on the highway or just like in the mud, and this thing works in the mud. [0:08:07] PJ Bruno: I think my favorite one is the Lincoln commercials with Matthew mcconaughey. [0:08:11] Kevin Wang: Oh those are incredible. [0:08:12] PJ Bruno: Those are great. Right? And it makes you want to hang with mcconaughey because he's being all like, "I was driving a Lincoln way before I was paid to drive one." [0:08:19] Kevin Wang: But the incredible thing is, I am convinced that that's actually what hanging out with Matthew Mcconaughey is like. These commercials... [0:08:26] PJ Bruno: Jumping into a pool wearing all of your clothes, an amazing three piece suit. [0:08:30] Kevin Wang: This is like, he does that like twice a day. Like that doesn't even own a shower. Just like, "I just jump in my pool. It's just a great day." [0:08:38] PJ Bruno: So the next one here, we have Slack. You want to open up on this one Kev? [0:08:42] Kevin Wang: Yeah. Slack is again, phenomenal business. These are all phenomenal business. [0:08:46] PJ Bruno: Phenomenal product, I live in it. I live in Slack. [0:08:49] Kevin Wang: The amount of time that I've spent in Slack, I mean, we set this time up in Slack. It's so pervasive. I think one of the real challenges I have with Slack though is just that, Slack has some of the properties of email. Like I have something to say. I take that thing I have to say, I sent it to you and it's in a place where you can find it, but just the volume of traffic that goes through Slack, warps it into a completely different beast. I find this isn't maybe the most flattering characterization, but I think of Slack as almost like a screaming river of voices that's constantly flowing by you and occasionally you hear your name and you stick your head underneath the water and you just hear even more voices and it's madness. And then if you walk away, you don't know even what flowed past you, "Did I miss something important? Did I miss nothing important?" I think this is one of the real challenges of modern life speed of modern life, speed of electronic communication and Slack is not necessarily causing that, but there are certainly privy to that transformation and reduction of attention spans and all of that. But on the other hand it's really effective. It's really efficient. I rarely look at Slack and think, "Wow, this is impeding me from doing something." And so I think that their future is incredibly bright. They just need to figure out a way to help people manage the world in which they were created. [0:10:15] PJ Bruno: I think you're right. I think we just need that layer of like how to manage Slack and not get lost in it. But yeah, I think it's also since the barrier to initiate conversation is way lower. It's just like the simplicity of it, that makes the communication volume much higher. And then the importance of the message is often decreased. I mean, I send plenty of messages on Slack that are not that important. To me, I chalk it up to culture ads, giving kudos to someone, like making someone feel comfortable. Giphy obviously like... [0:10:51] Kevin Wang: I love Giphy. [0:10:51] PJ Bruno: I mean, what an amazing creation that is. [0:10:53] Kevin Wang: Yeah. Genius. Something like printing press. [0:10:56] PJ Bruno: I know. [0:10:56] Kevin Wang: Exactly. [0:10:57] PJ Bruno: [crosstalk] get better please. But yeah, no, I mean, but at the end of the day, it's just a matter of convenience. And because it is so convenient, it's just so easy to put your time into it. And earlier I liken it to the Jewel, right? As opposed to smoking cigarettes, you need to walk outside, you need a lighter, you need to light that up and the jewel and vapes have made it so easy to just smoke wherever you are. And usually it's fine to be indoors and so you're doing it a lot more. And so I think there's that pendulum swing, when it moves to the left, as it moves to the right, it gets more and more convenient and it makes your life easier but at some point you're utilizing it so much because you think that convenience makes it more available to you to use as often as you want. And so then you use it, maybe when you don't actually need it. [0:11:47] Kevin Wang: Yeah. I completely agree with you. And I think one of the interesting things with Slack is that, it doesn't devolve to madness because of the tool itself. The tool is just the tool and it's a high quality product. It starts this descent into madness because of social constructs or more broadly the lack of social constructs around Slack. Because I mean the way that I view it as, we're all still mammals using this product Ed. We're all still just social animals, but all of the restraint that comes from not wanting to just go and tap someone on the shoulder and bother them and look at the look on their face of, "Who are you and why are you tapping me?" Like that just completely disappears in Slack. I mean, one of the things that I almost wish you could see in Slack was in a large channel, I wish you could just see that face of every single person that a message was about to go to because I think that the range of nonessential communication that goes on there would not be nearly as broad as it is. I mean, it's the equivalent of going into an auditorium and just tapping on the mic and say you declaring some large funny Gif to this entire audience, nobody would do that. And this ties into something else that I'm really excited to chat about, which is this idea of when we're looking at these new communication methods, when we're looking at these new channels, how do we actually decide, or how does one know what's going to be successful and what's not going to be successful? So this is a question that we ask at Braze. All the time on the product team. We're a product that crosses many different channels, many different ways of reaching end users or customers of a particular brand. And really our raison d'etre, our reason for being, is very much to help to bridge that gap and allow brands and their customers to have these much tighter, more personalized, richer experiences. But the question that we are constantly asking as a result is when there's some new technology announced like a magic leap, for example, something very next level augmented reality. What's going to make sense? And what's going to just be another palm pilot? And how do you time the market around these technologies to figure out where you're going to invest your time and your energy researching. And one thing that I always come back to, just from almost a first principle standpoint, is what are our brains actually evolved to handle? What are our brains good at? Because if we look back historically, that tends to be a major impact of the technologies that ended up succeeding. Humans are very visual creatures. So we like having really big TVS and we've just seen TV's get bigger and bigger and bigger because we like looking at stuff. I'm humans are also very auditory creatures like we speak to one another. That's one of our primary communication methods. And so that I think explains a lot of the success historically of radio now of podcasts and audio and things like that. And also to a lesser extent, we're also very tactical creatures. Like we have really fine grained motor control. That's how we can handle so much of the world's input in the business context is now handled via typing whether on a phone or whether on the keyboard of just because we have that control. And those are the sorts of trends. Those are the sorts of kind of universal truths that are going to continue to carry forward with us. Because we see now technology's changing so fast that within a single career, let alone a lifetime, you will see multiple technology waves crash and crest over you. But the brain and the raw tools and material that we're using to interact with these technologies is exactly the same. It's going to be the same now, it's the same with our kids and our children's kids. And so that is I think, a really strong leading indicator in terms of what is going to be successful and what is not. [0:15:32] PJ Bruno: And so real is the idea. It's funny because it's an idea that's been around for a while and that's when our technology has far surpassed, the evolution of our minds and have like our social constructs. Now we're really getting into that place, aren't we? Where technology is going to exponentially be zooming past maybe what we're able to handle as human beings. [0:15:55] Kevin Wang: Yeah, I think so. And as a result, everything that zooms too far is generally speaking, going to just not be that successful. And so I think part of the challenge that we have in the challenge that a lot of businesses, a lot of brands have, it's figuring out for your brand, for your use cases, what actually makes sense given that the raw materials of humanity aren't going to change. But everything that we can do to those raw materials is changing and expanding. One example that one of the engineers on our team likes to bring up is that, I don't know if you've seen the movie minority report? Minority report has the scene where they basically,[inaudible] yeah, that huge iPad. And Tom Cruise... [0:16:34] PJ Bruno: Yeah paint the picture for us, for those of you at home who haven't seen the film, this scene. [0:16:39] Kevin Wang: It's got Tom Cruise, he spends the whole time during the Tom Cruise thing where he alternates between looking really serious and looking like he's in a real rush. The whole movie, that surprised but hurried expression. Like you're bothering them a lot at McDonald's or something. And so there's this whole scene where they have basically a huge touch screen and it looks just incredible because it's flashing lights and it's flashing colors and like beeps and boops and people love that stuff. When I saw, I was like, "This is the greatest thing ever. I want it. I don't know why. I just want it." Like watching an apple keynote, like I want it and I've no reason for this. But suddenly this engineer at our team like to point out, I'm not sure if he thought this or he'd just read somewhere else, but I think it's a great salient point, is that nobody wants to go and poke a UI that's on the wall because nobody has arms are physically set up to just be stuck out pointing at stuff all day. Like that would just be an exhausting thing. And that's just a mechanical aspect of your arm, that like your arm is just not good at being fully extended or even partially extended for a long period of time with you standing up, especially without you getting really annoyed. And that's something that helps you predict something about technology. But you almost didn't even need to know anything about the tech. He didn't even need to see it. You just needed to know about like body position and purpose. [0:17:57] PJ Bruno: What does it take physically to use it? [0:17:59] Kevin Wang: Exactly. And it's the same reason that there've been jokes about like smellovision TVs forever, but no one cares because like human beings have a terrible sense of smell. Like this is why dogs are but men or women's best friend because dogs are really great at smelling, they're really good at tasting things and deriving information from that, their auditory range is fairly different from ours. So they can pick up on different cues than we can and as a result smell is like a useless thing to us. There's no iPhone for smell. There's not going to be, in my opinion. [0:18:31] PJ Bruno: Probably not. [0:18:33] Kevin Wang: Let's hope not. That'd be gross. [0:18:36] PJ Bruno: What about touch? [0:18:38] Kevin Wang: Yeah. I think touch is a really interesting one. Like your brain devotes a pretty decent chunk of its size to touch and management of touch. But I think what's kind of interesting about that one is that these very fine grade motor skills are something that you can learn and you can adapt to. Like, everybody I know who first got a touchscreen smartphone a little bit later on in life. Everybody liked that, struggled with it initially but was able to learn it because I mean, and I think that maybe this is getting a little too Scifi fantasy out there, but I think it's literally just because in an evolutionary sense, if you weren't able to, as a cave person, learn how to use very fine grained motor skills and train very fine grained motor skills that was like just not good for your overall evolutionary prospects. And so we all in the modern world retain that and we're really, really good at that. But I think that what's interesting with touch is that we're ultimately somewhat limited in that we can only gather so much data out of a particular situation because something like reading or hearing allows for much, much faster structured information input. Which is why those are the two channels which have just by far outclassed everything else in terms of the overall interactions. [0:20:02] PJ Bruno: And so I mean, for the sake of getting Scifi fantasy, because I know you like Scifi and I do too. [0:20:08] Kevin Wang: Of course just pass me the fourth. So very timely. [0:20:13] PJ Bruno: So I mean obviously we're not talking product roadmap, we're not talking about what's on the future for Braze product. But when we talk about data inputs, like once you surpass the channel or the device I mean, is it like physical augmentation like chips and like to contact lenses? Is that the next for the way we are going to be receiving our messages? [0:20:41] Kevin Wang: Yeah. So my own personal belief is that some form of onboard augmented reality is the future in the sense of being the next step for displays. And that just comes from a few core beliefs. And this being a potential logical conclusion from that. So the first one is that at any given point in time since basically the printing press and even before that, any visual communication method has been really, really important. So we've got printing press, you've got newspapers, TV, books, computers, smartphones. This is just a way of engaging in information that is really, really popular with people. This is obvious stuff. [0:21:23] PJ Bruno: Right. Groundbreaking. [0:21:25] Kevin Wang: Yeah, exactly. People like their eyes. It's like, not really changing anything now, but I think what's also interesting in terms of being very relevant to AR is that the way that people, that a lot of the capabilities that will be possible, I will hope, with augmented reality, add new dimensions to that and accentuate the ability to which we can use vision. So, two of the main ones are that, so you can imagine more sophisticated augmented reality systems that track where your eyes are looking because the actual amount of the actual area that's really tightly in focus of your visual field is very, very small. Relatively speaking. Most of it is peripheral, and it's not as focused in. And so augmented reality that's has the ability to take advantage of that. Because this is literally just more information into a system. And then the other thing that I think is interesting is that we tend to find experiences that are broader and take up more of our peripheral vision are more immersive. I mean this is why people still go to the movies. This is why people care about like retina screens and just big 4k TVs. And so there's clearly an aspect of human sensation and perception that's drawing us towards those more immersive experiences. But the other thing around AR that I think is really exciting is that it opens up, and this goes to your question about touch, it opens up a number of really interesting use cases around touch because it essentially frees up your hands if your monitor is always on, and it's on your face, and it's everywhere. And so again, we're evolved to handle it very physical and visual world. And so you can now imagine that we can have experiences for like educational technology where kids are looking at something and learning about or even learning to read, but they can actually physically touch something. Like you learn what a rock is, and it shows you how to spell a rock, spell the word rock or the type of rock that you're looking at, but you can actually pick it up and that just gives you all these different ways to imprint that learning. And the other thing is collaboration. So like something that I think is really valuable in the future is, when we're thinking about a presentation. This is something that should be fully interactive and can be fully interactive with augmented reality. PowerPoint should be something where I can point and like a laser pointer comes out of my finger, and I point at exactly what it is that I want to show you or I could zoom in or zoom out. All of that starts to become possible when we're getting into a world where everyone's display is on them or just the fact that, I mean something I think we talked about the other day, is that just physically the act of pointing is trying to get you PJ to see through my Kevin's eyes and with augmented reality or certainly hypothetical future versions of it. That's something that becomes directly possible. You could literally see what I'm seeing, and I think that it starts to go down a very powerful and very interesting road. If I had to pick, I'd also say probably apple is the best suited to really make a lot of this reality just because apple stuff is always really cool. And people like cool stuff. [0:24:34] PJ Bruno: That makes sense. And so I guess I got one final question for you and that is, is inception possible? [0:24:41] Kevin Wang: I also can't tell if that's a facetious question, but I'll just answer it dead serious, which is that, I mean I think that the true Scifi future that gets people all excited and if you really want to get the tech crunch articles running, you start talking about like what Elon Musk talks about with neural links, and literally that company, I think it's called Neuralink that he started, or he's saying he's going to start. And I think that that idea of how close, how bare to the metal can we get in terms of communication, like digital communication and hooking it up to your brain. This is the obvious conclusion in a certain sense of your brain should just be able to be extended in a digital fashion. But just to bring it back. I think that aspect of things in many ways goes back to the human aspect and that the blending of humanity and technology, which is that, if you have a system that requires doing surgery, if you have a system that requires very invasive procedures, this is just not something people like doing, like people don't like necessarily going in and doing very invasive things to their bodies. Even for these shorter term forms of entertainment or even or longer term forms of communication. So it'll be really interesting to see where that gets bridged. I mean, I know people who don't use contact lenses because that's something that they just find to be an uncomfortable experience. So at what point does society change enough that people are willing to accept that? I don't know. And I think that that's a really interesting question around both pure technology but also around uses of technology. Like things like privacy and security. So to what extent does a generation, five generations from now where they have, not only have they always had social media, but everyone who they ever meet their entire lives has always had social media? How does that person view the interaction between social media and social technology and their lives? It's probably very different from us, and that in turn is probably very different from folks would have a hundred years ago. [0:26:45] PJ Bruno: Kev, thanks for joining me on the communication episode. [0:26:48] Kevin Wang: Thanks so much. [0:26:49] PJ Bruno: You guys come visit us again? Take care. [0:26:51]

202: Playoff Implications w/ Kevin Wang (@kevkage_)

nba miami playoffs injury implications breakdown miami heat milwaukee bucks justise winslow kevin wang giancarlo navas brian goins

Play Episode Listen Later Apr 3, 2019 57:21

In this edition of The Heat Beat Podcast, we welcomed long-time friend Kevin Wang (@kevkage_) to join Giancarlo Navas, Alex Toledo, Brian Goins, and our newest contributor Genna Mark to discuss: • Breakdown of Heat-Celtics. What annoyed them about Monday's loss and what needs to change before Wednesday's rematch?• Injury status on Justise Winslow and Josh Richardson: Could J-Rich be out the remainder of the regular season? • The gang discusses how likely it is for Miami to get in the playoffs• Alex and Brian's theory on how Miami can possibly push the Milwaukee Bucks.

Snackable Fun - Revolution of Gen Z

Revolution Podcast

Play Episode Listen Later Dec 14, 2018 12:44

Il secondo episodio della serie di (almeno) 8 parti sui trend della Generazione Z. Trend approfondito: snackable fun. Con Stefano Daelli e Kevin Wang

revolution gen z trend snackable kevin wang

Detecting Traumatic Brain Injuries

Radio Cade

Play Episode Listen Later Dec 12, 2018

Traumatic brain injury (TBI) is hard to detect, and is sometimes called the “invisible injury.” Nancy Denslow, a scientist at the McKnight brain institute and cofounder of Banyan Biomarkers has developed a blood based test that will make TBI detection and treatment easier and faster Daughter of diplomat, was born and raised overseas in Mexico and Ecuador, and Turkey. “Petrified by Science” growing up her interest was changed by a great high school. TRANSCRIPT: Intro: 0:20 Inventors and their inventions. Welcome to Radio Cade, the podcast from the Cade Museum for Creativity and Invention in Gainesville, Florida. The museum is named after James Robert Cade who invented Gatorade in 1965. My name is Richard Miles. We’ll introduce you to inventors and the things that motivate them. We’ll learn about their personal stories, how their inventions work, and how their ideas get from the laboratory to the marketplace. Richard Miles: 0:38 This morning we have Dr. Nancy Denslow from Banyan Biomarkers. Welcome, Nancy. Dr. Nancy Denslow: 0:43 Thank you. Glad to be here. Richard Miles: 0:44 Nancy, tell us a little bit about yourself before we jump into asking you about the technology and its application. Just sort of where were you born? Were you raised to… How did you end up at the University of Florida? Dr. Nancy Denslow: 0:59 Well, my dad was a diplomat, so I was actually born in Mexico City while he was stationed there and I lived there six years and then after that I lived in Quito, Ecuador for six years and then in Istanbul, Turkey for three years. So I was a junior in high school before I came back to live in the United States. And from there I graduated from high school in Virginia, northern Virginia, and then went to college at Mary Washington College in Fredericksburg, Virginia, which at the time was an all girls school and majored in chemistry. Richard Miles: 1:33 What made you decide to go into chemistry? Was this something from a little girl that you’re interested in or was it a good high school teacher? What formed that decision? Dr. Nancy Denslow: 1:43 Actually, I was petrified of science while I was growing up, but then I had an excellent teacher in high school and that’s what turned my mind about it. And so that just goes to show what good teachers could do. Richard Miles: 1:55 So your undergraduate was in chemistry, is that correct? Dr. Nancy Denslow: 1:57 That’s right. Richard Miles: 1:58 Okay. And then your graduate work, you continued in chemistry and biology, is that correct? Dr. Nancy Denslow: 2:03 No. So the last year in chemistry. I had a course in biochemistry and I thought it was just really interesting. So I continued biochemistry and molecular biology. Richard Miles: 2:15 Got It. Okay. So let’s talk about the technology here that the thing that you invented, the company is called Banyan Biomarkers. Tell us a little bit what are biomarkers, but tell it to me as if I were a six year old who doesn’t know anything about anything and it’s not that hard for me to pretend, but really tell us how the technology works and what it does. Dr. Nancy Denslow: 2:41 Okay, so a biomarker is another method or is a method to identify an illness, let’s say. So in the case of traumatic brain injury, which is what our technology is about, we’ve identified proteins that actually make it into the bloodstream and these proteins can be detected by a specific assay that we’ve developed so that you can determine the extent of the brain damage by these biomarkers by measuring the proteins in the blood. So basically the technology is based on determining that these proteins are in the blood and we have antibodies that we’ve identified that are very specific to these proteins and so it’s a blood test and based on blood tests you could tell that a person has had traumatic brain injury. Richard Miles: 3:32 So for example, a football player, a soccer player, whatever, someone involved in an accident, they just come in. They give a regular blood tests for anything else or a donation of blood and then you can run this through an assay and figure out if there are biomarkers. Is that correct? Dr. Nancy Denslow: 3:50 Right. So if we take a blood sample and then you would run it through the assay and it would tell you the extent of the damage and that there has been traumatic brain injury. So it’s a way that perhaps one can avoid going for an MRI which has a lot more expensive and has radiation associated with it and so instead you would get a value that says, “Well maybe you should stay in the hospital for more observation” or “No, you know, it’s not really too bad. You could go home.” Richard Miles: 4:20 So is an MRI, is that the existing best technology or the most frequent one to identify traumatic brain injury? Dr. Nancy Denslow: 4:27 It is. Richard Miles: 4:28 Okay. So this sounds like it would be a lot easier and a lot cheaper. Is that really the main benefit of the biomarkers? Dr. Nancy Denslow: 4:38 Well, I think it’s a lot cheaper and easier as you’ve mentioned, but also there’s a potential that you may be able to attract the recovery from the traumatic brain injury. Richard Miles: 4:49 I see. Dr. Nancy Denslow: 4:50 No, we haven’t tested that totally, but it seems like it might be able to track recovery. Richard Miles: 4:56 So in theory then or maybe in practice just somebody comes in multiple times over a given time period and it’s just much easier to see what’s going on. Dr. Nancy Denslow: 5:05 Yes. Richard Miles: 5:05 Okay. Dr. Nancy Denslow: 5:05 So a person could maybe be in the emergency room and it could take a blood test over several hours and maybe you could get an idea of how stable that is or how stable the person is and whether they could go home. Richard Miles: 5:19 So right now the application that you have hit upon is traumatic brain injury, does a biomarker… Or do they have the capacity to track other types of pathologies or illnesses? Dr. Nancy Denslow: 5:31 Well, so we’re looking into that now. Richard Miles: 5:33 Okay. Dr. Nancy Denslow: 5:33 We haven’t established that yet. Richard Miles: 5:35 Right. Dr. Nancy Denslow: 5:35 But there’s potential. Richard Miles: 5:37 Nancy, tell us what was sort of the process. Was there an “Aha” moment or was it sort of a series of insights that got you to develop the biomarker? Dr. Nancy Denslow: 5:47 Well, actually this is a collaboration between three of us. Dr. Ron Hayes and Dr. Kevin Wang and myself. So Dr. Ron Hayes and Dr. Kevin Wang are neurobiologists that has been studying, traumatic brain injury for quite a while and my part was the proteomics part where it’s sort of a new science where you can study all of the proteins in a particular incidents and so we came together to figure out what was going on with traumatic brain injury and had the insight to look for these particular biomarkers in the blood. It was our idea that, well, if they were in the brain, they would probably get through the blood brain barrier and appear in the blood and if we could just attack them in the blood, then we would have a really good assay that could be beneficial to a lot of people. Richard Miles: 6:38 So was there one particular moment in which you realized, “We’ve got it. This is it. We’ve done it” or kind of just a slow dawning of… Dr. Nancy Denslow: 6:47 You know, we first could detect this, of course not in people, but in rats we could detect it and in the brain and the CNS fluids and so on, but it was thinking about whether they could be found also in the blood that spurred us to continue to try to develop this into develop antibodies that would be able to detect very minute amounts of the protein in the blood. So it was just a series of steps that got us to the point where we are now. Richard Miles: 7:15 After you came through or developed the breakthrough, you formed the company, Banyan Biomarkers. Tell me a little bit about that. What is the market that you’re looking at? Who is going to be the primary customer of this technology? Dr. Nancy Denslow: 7:31 So I think there’d be a lot of people that might be interested in this technology. For example, the military would be one for sure because they have a lot of people out where they could get hurt and with blasts and so on. And so they have really spurred us to develop the technology because they thought it would be very useful for the military. And then of course football players and other people of that sort or people who are in car accidents that might’ve had some kind of a traumatic brain injury. Or people just falling downstairs. So I think that there’s quite a bit of a market for this. Richard Miles: 8:06 So I’m assuming that there’s a real clinical advantage to having the ability to do this more quickly. So first of all, is it more rapid than an MRI? I’m assuming that it’s just a lot easier and faster to go in and get the blood, do the assay and come to your conclusion rather than an MRI, is that correct? Dr. Nancy Denslow: 8:25 That’s true. And right now we’re looking at various different partners that have platforms and hospitals and emergency rooms where they could put these antibodies on their platforms where everybody’s used to using those particular instruments already. And get a very quick readout. Right now, the assay is probably about an hour or so, but it’s possible that with different platforms that we could even shorten the time. Richard Miles: 8:52 So yeah, I could see like in a battlefield or someplace where you obviously don’t have access to an MRI, you could get a pretty good reliable result to very, very fast. Dr. Nancy Denslow: 9:02 We want to develop a point of care instrument that wouldn’t even have to be in an emergency room or anything like that, that could be out with the medics in the battlefield. Richard Miles: 9:11 Wow. Amazing. Dr. Nancy Denslow: 9:12 We’re not there yet. Richard Miles: 9:13 Not there yet. So tell me a little bit about the progress of the company. What would you say has been your biggest success to date and then if you want to share maybe your biggest setback to date in developing the technology. Dr. Nancy Denslow: 9:28 Well, I think the biggest success was we went into partnership with some new people that are based in California. And in fact our CEO is in California right now. And the people in the company that have developed the assay as it stands now are totally amazing. So they were very particular and very specific about meeting quality standards and making sure that the assay was sensitive and not overselling the assay as to what it could do and just being really very specific about what the assay could do. And then we ran a clinical trial with 2000 different blood samples. Some were controls and some were traumatic brain injured people and the samples were then sent to two different laboratories to run the tests. So the company didn’t run the tests themselves but sent the assays out to two independent laboratories to run the assays. And then they came back with just fantastic results. And so this is what we took to the FDA and this is what the FDA approved. So I think that that was just amazing to me how well that worked in terms of setbacks. You know, you think in antibodies working really well as you’re developing it and then you find that it’s not quite what you need. So you have to go back and you have to make a new one. So there were always two steps forward, one step back. It’s not that you could just go in and have the idea and do it. You just have to have the hard work that goes with it. Richard Miles: 10:56 So final question, somewhat similar. What has been your biggest surprise in all this as you develop the technology? Did you have people that you thought would love it and didn’t? Or vice versa? Did you, did you find people who were really interested in technology that you hadn’t thought about? Dr. Nancy Denslow: 11:10 Well, I think that as we’re developing this technology, people are becoming more used to a traumatic brain injury and football and what that might cause longterm problems to football players that there’s just been this whole interest in the whole country about doing something about traumatic brain injury. And here we were doing it. So that was just amazing how well that’s worked out. Richard Miles: 11:36 Nancy, thank you very much for being with us this morning. Outro: 11:39 Radio Cade would like to thank the following people for their help and support. Liz Gist of the Cade Museum for coordinating and inventor interviews. Bob McPeak of Heartwood Soundstage in downtown Gainesville, Florida for recording, editing and production of the podcasts and music theme. Tracy Collins for the composition and performance of the Radio Cade theme song featuring violinist Jacob Lawson. And special thanks to the Cade Museum for Creativity and Invention located in Gainesville, Florida.

united states ceo university california science mexico creativity turkey daughter fda ecuador mexico city istanbul invention mri aha traumatic gatorade gainesville tbi brain injuries traumatic brain injury detecting quito cns mcknight fredericksburg petrified kevin wang richard miles cade museum ron hayes heartwood soundstage

Digital Optimist - Revolution of Gen Z

Revolution Podcast

Play Episode Listen Later Nov 21, 2018 11:00

Il primo episodio della serie di (almeno) 8 parti sui trend della Generazione Z. Trend approfondito: Digital optimist. Con Stefano Daelli e Kevin Wang.

digital revolution gen z trend optimists kevin wang

Commons Clause with Kevin Wang

Open Source – Software Engineering Daily

Play Episode Listen Later Nov 5, 2018 63:37

Open source software powers everything we do on the Internet. Google runs on Linux servers. Content sites are served by WordPress. Our data is queued in Kafka clusters and stored in MongoDB instances. The success of an open source project often leads to the creator of that open source software becoming wealthy. An open source The post Commons Clause with Kevin Wang appeared first on Software Engineering Daily.

google internet open wordpress linux kafka mongodb software engineering daily kevin wang commons clause

Commons Clause with Kevin Wang

Greatest Hits – Software Engineering Daily

Play Episode Listen Later Nov 5, 2018 63:37

google internet open wordpress linux kafka mongodb software engineering daily kevin wang commons clause

160: Kind of An NBA Finals Preview w/ Kevin Wang (Bench Buckets)

game nba nba finals boston celtics bench miami heat finals preview buckets kevin wang christian hernandez giancarlo navas brian goins

Play Episode Listen Later May 30, 2018 43:24

In this NBA Finals Preview edition of The Heat Beat Podcast, Giancarlo Navas, Christian Hernandez, Alex Toledo, and Brian Goins invite Kevin Wang of Bench Buckets to discuss:• Game 7s galore/Cavs-Warriors IV (NBA Finals Preview...sort of)• NBA players who can't shoot have some damn nerve to wear a shooting sleeve (i.e. Andre Roberson)• Have we ever used analytics to help us play pickup basketball?• Why has everyone forgotten about Miami LeBron except for Celtics fans?…this and so much more!!!

155: Embiid is Greg Oden with Wi-Fi w/ Israel Gutierrez (ESPN), Tim Bontemps (Washington Post), & Kevin Wang (Bench Buckets)

Play Episode Listen Later May 11, 2018 63:06

In this NBA playoffs edition of The Heat Beat Podcast, we enlist Israel Gutierrez (ESPN), Tim Bontemps (Washington Post), and Kevin Wang (Bench Buckets) to help us preview the Eastern/Western Conference Finals between Celtics-Cavs and Rockets-Warriors. • What is Pat Riley's Plan A this offseason, and is it mostly filled of "What Ifs" at this point?• Are the Boston Celtics young stars and defensive acumen be enough to overpower LeBron?• How are we still underrating the Warriors' excellence? Is James Harden going to crumble under pressure yet again?• We rank the most annoying Sixers players and fattest NBA players of all-time....and so much more!!!

Ep. 37: Getting Swept LePronto

game philadelphia rockets toronto raptors steve kerr swept alex le kevin wang

Play Episode Listen Later May 6, 2018 52:11

Kevin Wang and Alex Le return to discuss the ongoing second round playoff series. They dive into the end of Game 3 between Boston and Philadelphia, Kevin dives into Brad Stevens' ATOs, LeBron rips out the Raptors' hearts again, Steve Kerr's rotations ruin gamblers' lives, and the Rockets respond in Game 3.

Ep. 36: To Home Dipo We Go

game lebron james nba playoffs toronto raptors russell westbrook cleveland cavaliers pacers brad stevens dipo alex le kevin wang

Play Episode Listen Later Apr 30, 2018 52:50

Alex Le and Kevin Wang return to give their predictions for the second round matchups of the NBA Playoffs while recapping the first round. They discuss Game 7 between the Cavs and Pacers, the Raptors' chances against LeBron, Westbrook's polarizing playstyle, potential Brad Stevens chess moves against Philly, and more. At the end, Alex goes over the guidelines of the bet, while explaining his disdain for boneless wings and spicy food.

Ep. 35: Tim Frazier With a Soundcloud

portland soundcloud warriors nba playoffs pelicans damian lillard tim frazier kevin wang

Play Episode Listen Later Apr 22, 2018 81:58

Kevin Wang is joined by Andrew Doxy and Alex Kungu to dive into the opening week of the NBA Playoffs. They discuss questions surrounding Portland's offseason and whether Damian Lillard's jumpshot is more or less effective than his bars. The three give a quick preview of Pelicans vs Warriors, along with their predictions. They debate if Heat-Sixers is over (it probably is). The crew vindicates Weird Celtics Twitter, discusses this unique community, and much more.

Great Joy and Hope

WSCAL - Morning Devotions

Play Episode Listen Later Apr 10, 2018

Why does Mary praise God the way she does when she visits Elizabeth in Luke 1? Mary's use of Hannah’s words in 1 Samuel gives us a glimpse of the great joy and hope Mary has in the coming Messiah.

god new testament great joy kevin wang

Ep.23 With Kevin Wang On Agri-business Capabilities And Trends

Austrade China Podcast

Play Episode Listen Later Apr 2, 2018 16:30

Agri-business makes up a key pillar in the Australia-China trade relationship. With the China-Australia Free Trade Agreement (ChAFTA), exciting cases have been emerging in this sector continuously. Austrade Shanghai Business Development Manager Kevin Wang joined the show and shared some observations regarding Australia's advantages, China's market needs, and the future trends in this primary sector. Share your views or questions with us at ChinaPodcast@austrade.gov.au. To seek Austrade's assistance, please contact your local Austrade and/or TradeStart team at austrade.gov.au or call 13 28 78 from Australia.

australia china capabilities agri australia china austrade kevin wang

Ep.23 With Kevin Wang On Agri-business Capabilities And Trends

Austrade China Podcast

Play Episode Listen Later Apr 2, 2018 16:30

australia china capabilities agri australia china austrade kevin wang

Ep. 33: Fixing Kevin's Bracket

michigan warriors fixing bracket unc trae young collin sexton alex le justin hodges kevin wang

Play Episode Listen Later Mar 15, 2018 66:39

Kevin Wang, Alex Le, Justin Hodges, and Jackson Frank Ranking the top prospects at the Center position. Collin Sexton vs Trae Young. Various soliloquies from Justin. Helping Kevin with his bracket. Potential upsets. Michigan vs UNC. The Warriors will repeat. Justin gets his Twitter suspended.

Ep. 31: More Drunk Than Jimmy Butler?

Play Episode Listen Later Feb 22, 2018 84:33

Kevin Wang, Giancarlo Navas, and Justin Hodges Recap of Episode 46 of Boruto. The nostalgia from the Naruto-to-Boruto transition. Giancarlo's deep disdain for Sasuke Uchiha. Tsunade vs Jiraiya. Sports Illustrated's piece about the Dallas Mavericks' horrid work environment for women. Fergie's anthem performance. Jimmy Butler experiences.

drunk dallas mavericks sports illustrated jimmy butler naruto fergie giancarlo boruto jiraiya tsunade kevin wang sasuke uchiha giancarlo navas

The UchiPod Clan - Ep. 2

talk predictions ranking clan gekko konoha kevin wang

Play Episode Listen Later Feb 17, 2018 44:03

Kevin Wang and Justin Hodges Review of Episode 45. Predictions for Episode 46. Shikadai's failure at Talk no Justsu. Ryogi potentially switching sides. Gekko, the good uncle, or the manipulative gang leader? Ranking the Konoha 12.

Ep. 30: A New Hill to Climb

nba climb all star weekend alex le kevin wang mudiay

Play Episode Listen Later Feb 12, 2018 78:47

Alex Le, Kevin Wang, and Jackson Frank The Cavaliers make multiple splashes before the trade deadline. Mudiay to the Knicks? Buyout candidates. The end of Derrick Rose? Paul Pierce slander. All-Star Weekend. NBA's rising 3-point attempt rates.

Ep. 29: Fire Drills

miami boogie detroit pistons pouring lou williams avery bradley spoelstra fire drills alex le kevin wang

Play Episode Listen Later Feb 4, 2018 43:36

Alex Le, Kevin Wang, Shameek Mohile, and Robert Flom The Clippers and Pistons complete a blockbuster trade. More trades from the Clippers? The Pistons' playoff chances. What is Boogie's future with New Orleans? The Cavs hit a new low that few thought were possible. Pouring one out for Lou Williams. Robert's distaste for Avery Bradley. Spoelstra and Miami. Kevin's dorm catches fire.

Season 2: Outside In

Greyscale

Play Episode Listen Later Feb 2, 2018 21:41

Kevin Wang, faculty at Swedish First Hill Family Medicine Residency, discusses his journey through the medical education system as we get a glimpse of how LGBTQ healthcare and medical education has evolved and where it can continue to improve.Swedish LGBTQ - Trans Healthcare Symposium: https://www.swedish.org/for-health-professionals/cme/conferences/trans-healthCultural Awareness Training & LGB Education· Fenway Institute: https://www.lgbthealtheducation.org/lgbt-education/learning-modules/· Cardea Services: http://www.cardeaservices.org/training/providing-culturally-proficient-services-to-transgender-and-gender-nonconforming-people.html· Gay & Lesbian Medical Association: http://www.glma.org/index.cfm?fuseaction=Page.viewPage&pageId=1025&grandparentID=534&parentID=940&nodeID=1· His Health: https://www.hishealth.org/· Fenway Institute: https://www.lgbthealtheducation.org/lgbt-education/webinars/ Trans Medical Care & Statistics· National Transgender Discrimination Survey: https://transequality.org/issues/national-transgender-discrimination-survey· University of California San Francisco Center of Excellence for Transgender Health Guidelines: http://transhealth.ucsf.edu/trans?page=guidelines-home· Cedar River Clinics Trans Toolkit: http://www.cedarriverclinics.org/transtoolkit/· Callen Lorde Trans Protocols: http://callen-lorde.org/transhealth/· World Professional Association of Trans Health Standards of Care Version 7: http://www.wpath.org/site_page.cfm?pk_association_webpage_menu=1351&pk_association_webpage=3926· Fenway Health Trans Guidelines: http://www.lgbthealtheducation.org/wp-content/uploads/COM-2245-The-Medical-Care-of-Transgender-Persons.pdf Other· HealthyPeople 2020: https://www.healthypeople.gov/2020/topics-objectives/topic/lesbian-gay-bisexual-and-transgender-health· LGBT Health Journal: http://www.liebertpub.com/lgbt· Transgender Health Journal: http://www.liebertpub.com/overview/transgender-health/634/

university lgbtq excellence medical care pageid world professional association kevin wang nodeid transgender persons lesbian medical association

Ep. 28: Changes On the Horizon

fake warriors horizon san antonio spurs kawhi leonard john wall jason kidd lonzo fultz team lebron point contest kevin wang

Play Episode Listen Later Jan 26, 2018 54:27

Kevin Wang and Alex Le Team Steph and Team LeBron dissections. January Cavs concern levels (again). Alex provides his rationale for hating the Warriors (again). Jason Kidd's firing and the resulting optimism. Kawhi and the Spurs. Fake trades. John Wall's underwhelming season. Lonzo and Fultz for the 3-Point Contest?

Ep. 27: Dolls and Tunnels

dolls damian lillard tunnels mirotic kevin wang

Play Episode Listen Later Jan 17, 2018 62:52

Kevin Wang, Nekias Duncan, Justin Grant, and Austin Hutchinson Cavs-Warriors reactions. January Cavs concern levels. What will ultimately break up the Warriors? East and West All-Star roster predictions and snubs. Nekias addresses Damian Lillard's constant underdog mentality. Austin becomes the Mirotic truther. Best tweets from the sex doll and Rockets-Clippers Twitter fiascos.

Ep. 26: I'm Already Halfway There

nba west east heat los angeles clippers halfway jimmy butler andrew wiggins polarizing julius randle alex le kevin wang

Play Episode Listen Later Jan 13, 2018 63:16

Alex Le and Kevin Wang are back at the midseason point of the 2017-2018 NBA season. Midseason Award winners. The January Cavs. Where is Jimmy Butler's place among the NBA's upper echelon of stars? The "New Offense Who Dis" Raptors. Heat and Clippers continue to scrap for victories. Polarizing players in Andrew Wiggins and Julius Randle. The bottom of the East and West playoff brackets.

Episode 30: Kevin Wang, Fossa

52 Founders

Play Episode Listen Later Jun 27, 2017 28:29

In this episode, you’ll hear about: -Who the ideal Fossa customer is, and why enterprise companies are not the only ones who care about code quality and security -The evolution from TLDRLegal to Fossa, and the opportunity Kevin saw to create a sustainable business -How attending the Illinois Mathematics and Science Academy boarding school shaped Kevin’s childhood and led to his early independence -How Kevin’s parents, who emigrated from China, were the driving force behind his technical education -The “dual life” Kevin led growing up between school and freelance coding, and how the latter became his motivation to start a company -How working at Techstars Chicago marked the beginning of Kevin’s startup journey, and why he decided to move to San Francisco Be sure to stay tuned at the end of the episode, where Kevin shares some favorite Bay area companies and explains why there isn’t just one person he would most want to interview.

china bay fossa science academy kevin wang techstars chicago

Andrew Teoh: China’s Tech Unicorns May Grow As More Second-Tier Firms Merge In 2016

China Money Podcast - Audio Episodes

Play Episode Listen Later Dec 14, 2015 28:02

In this episode of China Money Podcast, guest Andrew Teoh, founding partner of Ameba Capital, spoke to our host Nina Xiang. Teoh shared his views on potential mergers among Chinese tech companies that could take place in 2016, what start-ups China's BAT (Baidu, Alibaba, and Tencent) are looking to acquire right now, and if Chinese venture capital investments will cool further next year. Don't forget to subscribe to China Money Podcast for free in the iTunes store, or subscribe to China Money Network weekly newsletters. You can also subscribe to China Money Podcast’s Youtube channel or Youku channel. Q: Give us a brief introduction of Ameba Capital? A: We were founded in 2011 by three partners, former Kingsoft chief financial officer Kevin Wang, Koubei.com's founder Frank Lee, and myself. We focus on making early-stage investments in the technology sector in China, and have invested in numerous companies. Some of our more well known portfolio companies include Kuaidi, or now Didi Kuaidi, Mogujie, and the merged Meituan Dianping. Q: That's three unicorns right there, but we will talk about that later. You also had an interesting career before co-founding Ameba. Can you tell us a bit more? A: I was born and grew up in Malaysia, but also worked and lived in Australia, Hong Kong and Beijing. I joined Alibaba in 2005, when the company had slightly over 1,000 employees. By the time I left, Alibaba had over 20,000 employees. I was involved in Yahoo's investment in Alibaba, Alibaba.com's Hong Kong initial public offering in 2007, and Alipay's restructuring, during a period of the company's rapid growth. Q: What did that experience teach you about investing as a venture investor? A: I realized that a company is very much like any other living form. It grows and changes. I was dealing with issues and transactions signifying the stage of growth the company was in. Now as an investor in small start-ups, I'm dealing with early-stage growth similar to a child's growth. I was able to use my experience at Alibaba to help start-ups enter their next phase of expansion, and help them solve the challenges in that process. Q: Ameba Capital closed a second fund, bringing total asset-under-management to RMB1 billion (US$160 million). How was the fundraising process? A: It didn't take that long. The fund was filled up just from commitments from existing investors to our first fund. My partners and I are still the single largest group of investors in the fund. Q: Would you consider raising a U.S. dollar fund? A: I will never rule that out, but the capital markets in China have changed a lot during the past year. RMB as a form of investment currency will become more important, especially in the tech world. When I started Ameba, it was rare to see RMB-denominated institutions investing in technologies because a lot of capital was from U.S. dollar funds, and exits were all overseas. But that is changing rapidly. There are more exits domestically, also more M&A happening among domestic firms. Q: So you see more RMB funds to be raised, more domestic listings and deals happening in the future? A: Yes, we will see that both in early-stage and late-stage investments. I think that's very healthy, and it shows that our format has worked. Q: How much do you invest per deal, and how many companies have you invested in total? A: For our second fund, we invest in pre-A and series A rounds, so from a few million RMB to tens of millions RMB. Cumulatively, we have backed around 60 companies. Q: In terms of strategy, will there be any changes from your previous focus on e-commerce, corporate services, advertising, etc.? A: We will continue our strategy to focus on the data aspect of e-commerce, a very niche market of advertising. We also like a few verticals such as healthcare and education. Our sector focus hasn't really changed, but the companies operating in these areas have changed...

Interview with Dr. Danielle Ofri

History & Physical: The Official Medical Student Podcast of in-Training

Play Episode Listen Later Jul 1, 2014

This week on History & Physical, Kevin Wang interviews Dr. Danielle Ofri. Dr. Ofri is the author of The New York Times best-seller "What Doctors Feel," editor-in-chief of the Bellevue Literary Review, contributor to The New York Times, associate professor of medicine at New York University School of Medicine, and internist at Bellevue Hospital. The post Interview with Dr. Danielle Ofri appeared first on in-Training.

history interview school education technology training new york times medicine student medical new york university premed bellevue hospital bellevue literary review danielle ofri ofri kevin wang premedical

#46 - 和为知笔记的 CTO 聊聊他的经历和技术

Play Episode Listen Later Mar 9, 2014 98:52

本期由Kevin Wang主持, 和为知笔记的CTO老魏聊聊他的入行经历，以及他们产品中的一些技术选型。 Pascal Fortran Tubo C Tubo Pascal WPS Office 为知笔记 Markdown LaTex FrameMaker InDesign WizQTClient iconfont Paradigms of Computer Programming Special Guest: 老魏.

cto pascal paradigms latex markdown indesign computer programming fortran kevin wang turbo pascal wps office

#39 - SaaS 产品血泪史

Play Episode Listen Later Nov 17, 2013 104:41

在本期的节目 Teahour 迎来了新的主播 Xdite! 这期的节目由三位主播 Kevin Wang, Dingding Ye 和 Xdite 主持，吐槽和痛诉开发和经营 Fengche.co 和 Logdown SaaS 产品的血泪史。一些讨论到的点：介绍了两个人分别在操作的产品你认为什么是 SaaS 怎么起步，怎么选择这个方向往回想，如果重新来一遍，起步时你会有变化吗？产品的开发过程是如何的？上线后发生了什么事情，如何找人，如何前进？至今你做了哪些调整？调整的决策是如何的？ SaaS Logdown Fengche.co Tealeaf Academy Rocodev Intridea HackerNews groovehq 37signals Basecamp Trello Business of Software Kathy Sierra's BoS Keynote Penflip Editorially Teahour 线下活动 Special Guest: xdite.

business software saas trello basecamp hacker news kevin wang editorially teahour

#35 - 和魏伦谈远程团队和远程工作

blog cto campfires trello concentrate jira weibo toggl kevin wang exercism planning poker

Play Episode Listen Later Oct 20, 2013 101:38

本期由 Kevin Wang 主持，邀请到了魏伦, Bindo Labs 的 CTO 来谈远程团队的建设和远程工作的体会. 魏伦的联系方式： Blog Weibo Bindo Labs Fengche.co Redmine Trello Jira Toggl Planning Poker Intridea Campfire Rails Jobbers Tealeaf Academy 爱燃烧比赛控 Exercism 寿司之神 Concentrate Special Guest: 魏伦.

#31 - 跟易空海创始人 Maxime 聊如何运作一个咨询公司

Play Episode Listen Later Sep 11, 2013 87:30

本期由 Kevin Wang 和 Dingding Ye 共同主持，我们邀请到了易空海的创始人和 CEO Maxime Guilbot 来跟大家聊聊关于做 freelancer 和 consulting firm 的一些分享。如何起步，如何找到新的客户和项目，如何选择合适的客户合作，如何和客户沟通，如何做项目预算评估，如何在客户的预算成本下做项目，如何建立一个好的团队，如何管理项目和一些开发流程，Maxime 分享了他在易空海是怎么做这些事情的。易空海 HashRocket PickFu RubyConf China better_errors 实用 Git 工作流 Special Guest: Maxime Guilbot .

ceo maxime git kevin wang hashrocket

#21 - 跟天使湾聚变计划负责人王磊聊天使投资

entrepreneur peter thiel yc weibo odesk mark suster kevin wang

Play Episode Listen Later Jul 1, 2013 115:53

本期由 Dingding Ye 主持，Kevin Wang 联合主持，邀请到现天使湾聚变计划负责人王磊来聊聊天使湾、种子投资和天使投资。王磊的一些联系方式： Weibo Email 天使湾聚变计划 YC 小恩爱 Code4App 左耳涂鸦王国 Mark Suster Peter Thiel Fengche.co Tealeaf Academy 旅行的艺术 oDesk Entrepreneurs are the new labor Special Guest: 王磊.

#18 - 采访《七周七数据库》作者 Eric Redmond - 数据库的故事

Play Episode Listen Later Jun 3, 2013 121:57

本期由 Kevin Wang 主持，Dingding Ye 协作主持，邀请到《Seven Databases in Seven Weeks》作者 Eric Redmond 畅聊数据库。Eric 目前是 Riak 的核心开发人员，在两个小时时间了，Eric 介绍了 PostgreSQL、MongoDB、CouchDB、HBase、Cassandra、Redis、Riak、Neo4J 的各自设计思想和优缺点，同时在最后也分享了他个人在数据库选择上的一些考虑原则。 Basho Seven Languages in Seven Weeks MongoHQ CAP theorem PostgreSQL MongoDB CouchDB HBase Cassandra Redis Riak Neo4J Dynamo VoltDB JUNG Cypher Eventual Consistency Google Glass Explorer Program The Little Riak Book Antifragile: Things That Gain from Disorder Hashrocket Lunch n' Learn with Eric Redmond Hashrocket Guest Star Interview: Eric Redmond Special Guest: Eric Redmond .

disorders cap jung redmond dynamo cypher mongodb eventual redis postgresql basho seven weeks neo4j antifragile things that gain couchdb kevin wang riak seven languages hbase

#16 - 采访暴走漫画 CTO 曹力(@ShiningRay) - 谈架构演进

Play Episode Listen Later May 19, 2013 93:40

本期由 Dingding Ye 主持，Kevin Wang 协作主持，邀请到现暴走漫画 CTO、博聆网创始人曹力(@ShiningRay)) 来聊聊暴走漫画的网站架构演进和性能优化的经验分享。曹力的一些联系方式： Twitter Weibo 屌丝程序员如何打造日PV百万的网站架构杭州 Ruby 开发者沙龙活动总结盛大云 nginx Membase redis Couchbase 又拍云 DNSPod New Relic 糗事百科 Percona MariaDB Scaling Rails Screencasts How We Went from 30 Servers to 2: Go delayed_job Sidekiq ab tsung High Performance MySQL Erlang Railsconf 2013 keynote LessConf MicroConf second_level_cache Kevin Dewalt's Blog Special Guest: 曹力.

cto servers pv weibo new relic erlang mariadb couchbase microconf railsconf kevin wang sidekiq percona

#12 - SegmentFault 和黑客马拉松之运营篇

Play Episode Listen Later Apr 14, 2013 71:33

本期由 Dingding Ye 主持，参与嘉宾有高阳，Kevin Wang 和 Daniel Lv。高阳是 SegmentFault 的联合创始人，专门负责运营这一块。本期高阳来到 Teahour，跟大家分享了一下他在 SegmentFault 的运营经验和他们举办的活动黑客马拉松。 SegmentFault SegmentFault 团队 Typeecho StackOverflow 黑客马拉松 tech2ipo 苍老师杜蕾斯官方微博微信公众平台富士拍立得 A Song A Day Raspberry Pi 动态网站静态化的产物 Teahour.fm Fengche.co Tealeaf Academy Special Guest: 高阳.

raspberry pi cn stack overflow song a day kevin wang teahour

#10 - 开源软件和 GitCafe

TheCreators2030 UN Arts Initiative

Play Episode Listen Later Apr 2, 2013 91:06

本期由Kevin Wang主持, 邀请到上海 Linux User Group 的负责人和 GitCafe 的创始人 Thomas Yao 来聊聊开源软件的话题和GitCafe 的创业经历。 Thomas Yao Shanghai Linux User Group GitCafe Debian Gentoo LFS - Linux From Scratch Arch Linux Richard Stallman GNU project Linus Torvalds Announcement of Linux Revolution OS Eric S Raymond GPL License MIT License Stinkybad 500px Fancy Overapi Martin Fowler Ruby Rogue's Book Club with Martin Fowler Alfred App Special Guest: Thomas Yao.

announcement linux gnu debian linus torvalds richard stallman martin fowler gentoo arch linux kevin wang alfred app

Listen Give Live | Episode #50

Play Episode Listen Later Mar 20, 2013 60:00

Jaee Logan and Gail Davvis talk about music, arts, culture, society, youth, education and giving back. Join us with Guest, Nadine Levick MD, MPH, Founder/Director of IRescU discussing an APP created to support people connecting with Medical Service In Emergency Situations by Location (Guest Time Slot 3:10 PM EST to 3:25 PM EST); and Kevin Wang, TEALS Ringleaders of Microsoft & TEALS Program (Part of Microsoft) discuses the program's mission for Youth - Computer Science in Every High School and need for more Youth in America to learn Computer Science (Guest Time Slot 3:35 PM - 3:50 PM EST). Visit ListenGive.com to learn more information. Don't forget to LIKE our Facebook Page LISTENGIVE.

america education microsoft youth app location mph kevin wang listen give

#5 - Hardware for developers

Play Episode Listen Later Mar 5, 2013 84:27

本期由 Terry Tai 主持，参与嘉宾有 Daneil Lv, Dingding Ye 和 Kevin Wang。本期由所有Teahour创始人和大家一起聊聊开发中用到的硬件和选购的一些技巧以及如何锻炼和保护程序员的身体。 Macbook Pro Parallel Tests Ivy Bridge 硬件虚拟化超线程 Crucial M4 Samsung 830 Richard Huang Herman Miller Aeron Herman Miller Embody 锤子手机 QWERTY Dvorak Happy Hacking Keyboard Pro Type-S Razer Blackwidow For Mac Realforce 86U Tactile Pro Apple Extended Keyboard Alps Matias ADB Kinesis Freestyle mini Tactile Pro Shanghai Linux User Group Dell 2412M Jim Weirich Fitbit Zip Fitbit One Fitbit Flex Jawbone Up The Boy Scout Rule 钻石年代 Pocket Casts SuperDuper!

developers samsung flex hardware alps macbook pro pocket casts dvorak super duper qwerty adb kevin wang fitbit flex jawbone up jim weirich ivy bridge fitbit one superduper superduperdescription teahour

#3 - Interview with xdite on personal growth

Play Episode Listen Later Feb 9, 2013 81:01

本期由 Kevin Wang 主持，邀请了台湾著名 Rubyist 和技术博主 xdite。xdite 在去年的 RubyConf China 2012 里面给做了非常精彩的演讲，在本期 podcast 里她围绕着两条主线 1) 学习成长经历，以及从T客帮到创业的职业经历 2) 如何招聘，如何培养新人和团队管理，分享了个人心得。同时参与嘉宾有 Daniel Lv 和 Dingding Ye。 xdite T客邦 very XD MOOC Udacity Coursera Edx Stanford Open Classroom MIT Open Class iTunes-U xdite 第一家公司的协作方式 Fengche.co scrum kanban Rails 101 xdite's reading list Jesse Storimer Leaky Abstractions CSAPP The 100 words that will get you hired anywhere Special Guest: xdite.

massive personal growth xd rails scrum coursera kanban edx mooc udacity kevin wang rubyist

#2 - How to Learn Ruby and Rails